To investigate associations of polymorphisms in the LEP, LEPR and NPY genes with obesity-related traits in a Brazilian population of European descent. METHODS: A total of 183 women and 153 men (mean body mass index (BMI), 26.1 AE 4.8 kg=m 2 ) were genotyped using the PCR-RFLP procedure for the LEP A19G, LEPR Gln223Arg, LEPR PRO1019pro and NPY Leu7Pro polymorphisms. Frequencies were compared among normal-weight and overweight plus obese groups with chi-square tests, mean BMI and waist circumference were compared among genotypes by t-tests and analysis of variance. RESULTS: The genotype and allele frequencies of the LEPR Gln223Arg polymorphism were significantly different between normal-weight and overweight plus obese groups (P ¼ 0.013 and 0.009, respectively). Although there was no difference in the mean adjusted BMI among the three LEPR Gln223Arg genotypes, a trend was observed for Arg=Arg individuals to have a higher mean BMI compared to Gln=Gln homozygotes, with heterozygote individuals presenting intermediate mean BMI between the two homozygote groups (ANOVA, P ¼ 0.063). However, in non-smokers, the LEPR Gln223Arg polymorphism showed a highly significant effect over BMI (P ¼ 0.009). When the analysis was restricted to premenopausal women, a highly significant effect of NPY was observed. Women bearing the Pro variant presented a lower BMI than wild-type homozygotes (P ¼ 0.001). CONCLUSION: Our findings suggest that genetic variability in the leptin receptor and neuropeptide Y genes is implicated in body weight regulation, the LEPR Gln223Arg variant being associated with a BMI increase in this Caucasian population, especially in non-smokers, while the NPY Leu7Pro polymorphism was associated with BMI reduction in premenopausal women.
Introduction
The growing prevalence of obesity observed in many populations throughout the world and its major consequences for public health triggered a search, in the last years, for the candidate genes to play a role in the pathophysiology of this disease.
The leptin-signaling pathway is considered one of the most important routes involved in energy homeostasis regulation in the human metabolism. 1 The peptide hormone leptin is released from the adipose tissue and has been considered the primary signal through which the brain receives information about the size of the body energy stores and nutritional status. Leptin binds to its receptor in the hypothalamus, and participates in the regulation of food intake and energy expenditure by modulating the release of anorexigenic and orexigenic neuropeptides, among them neuropeptide Y.
The leptin (LEP) and leptin receptor (LEPR) genes have been extensively studied in the last years in the search of variants which could be important in the pathophysiology of human obesity. 2 -18 Although less studied, the neuropeptide Y (NPY) gene was also considered as a candidate for susceptibility to excess body fat accumulation. 19 -21 The coding sequence screening of the human LEP gene has not identified any polymorphism in this region, 22 but a frequent variant has been described in the untranslated exon 1 of this gene (A19G), 2 which was associated with a decrease in leptin levels 2 and obesity. 5 On the other hand, approximately 19 polymorphic sites were identified in the LEPR gene, 14 although there has been little consistency in findings of association studies published to date. A few polymorph-isms were described in the NPY gene, 20, 21 the Leu7Pro variant being associated with cholesterol levels but not obesity in one study. 20 Given the inconclusive nature of most studies published so far, it is necessary to perform further studies concerning these genes in other populations. So far, the South American populations have not been included in these studies, although obesity is becoming as important an issue in developing countries as in the developed nations. Thirtyfive percent of the Brazilian population have a body mass index (BMI) over 25 kg=m 2 , where marked increases in the prevalence of obesity have occurred in the last three decades, except in women from higher-income groups. 23 In the present study we analyzed four gene variants in the LEP (A19G), LEPR (Gln223Arg and PRO1019pro) and NPY (Leu7Pro) genes in a Brazilian population of European descent, and searched for associations of these polymorphisms and obesity-related phenotypes, specifically BMI and waist circumference (WC).
Subjects and methods

Subjects
Our sample consisted of 336 non-diabetic individuals of European descent residing in Porto Alegre, the capital of Brazil's southernmost state. This city was founded in 1752 by 60 Caucasian couples from the Azores Islands. Currently the population is still mainly of Portuguese descent, but Italians, Spaniards and Germans have also contributed to its gene pool. 24 The 183 women and 153 men who constituted our sample went to the Clinical Analysis Laboratory of the Pharmacy School of the Federal University of Rio Grande do Sul for routine blood tests, and may be considered a random sample of the city's population. They answered a questionnaire regarding health and lifestyle features, including smoking habits, alcohol consumption, medication intake, physical activity and menopausal status. All subjects signed an informed consent to participate in the study. Individuals with a previous history of diabetes mellitus or fasting glucose levels above 7.0 mmol=l 25 were excluded from the analysis to avoid the confounding effects of diabetes and its treatment on obesity-related traits.
Anthropometric measurements
The subjects attended the laboratory in the morning after a 12 h fast. Blood samples were collected and weight and height were measured. WC was measured at mid-level between the lower rib margin and the iliac crest. 26 Anthropometric variables were used to calculate BMI (weight (kg) divided by height (m) squared). Overweight was defined as a BMI over 25 kg=m 2 and obesity as BMI over 30 kg=m 2 , as defined by World Health Organization. 27 Central obesity was defined as a WC ! 102 cm for men and ! 88 cm for women. 27 
Biochemical analyses
Fasting glucose, total cholesterol, high-density lipoprotein cholesterol and triglyceride levels were determined enzymatically using commercial kits (Labtest) on a Selectra 1 autoanalyzer.
Genetic analyses DNA was extracted from whole blood using the procedure described by Lahiri and Nurnberger. 28 The regions containing the four polymorphisms were amplified by polymerase chain reaction (PCR) using primer pairs previously described. 3, 10, 9, 20 Separate PCR reactions were performed on total volumes of 25 ml, using 100 ng of genomic DNA, 0.3 mM of each primer, 200 mM dNTPs and 0.75 U Taq polymerase in standard buffer with 1.5 mM MgCl 2 (Amersham Pharmacia Biotech, Piscataway, NJ, USA), except the LEP A19G polymorphism, for which as MgCl 2 concentration of 1.0 mM was used and a hot start procedure was employed. Thirty-five temperature cycles with annealing temperatures of 69 C for LEP A19G, 55 C for LEPR Gln223Arg, 50 C for LEPR PRO1019pro and 63 C for NPY Leu7Pro were performed in a GeneAmp 9600 Thermocycler (Perkin-Elmer Corporation, Norwalk, CT, USA). PCR products were incubated with the restriction endonucleases according to the manufacturer's recommendations (MspA1 I, Msp I, Nco I and BsiE I, respectively, New England Biolabs, Beverly, MA, USA) and the digested fragments were separated by electrophoresis in 2 or 3% agarose gels, according to fragment size resolution.
Statistical analysis
Allele frequencies were estimated by gene counting. The agreement of genotype frequencies with Hardy -Weinberg expectations was tested using the chi-square test. Frequencies between groups were compared by chi-square tests using the GraphPad InStat software version 2.04a (GraphPad Software, San Diego, CA, USA) and adjusted residuals were calculated with the PEPI statistical programs Version 4.0. 29 Multiple linear regression models were constructed separately for each sex, to perform adjustments of BMI and WC for the effects of metabolic and environmental variables, assessed during the patient's interview. The effect of each variable on the dependent variable (BMI or WC) was previously evaluated, separately, and they were added stepwise to the regression model. Only the variables which contributed significantly to each model were kept. The following variables were tested: age, physical activity, alcohol consumption, smoking, oral contraceptive use and hormone replacement therapy (the last two only in women). Menopausal status was not included in the models due to its high correlation with age. Lifestyle factors were included in the regression models as 'dummy' variables. According to these criteria, BMI was adjusted for age and oral contraceptive use and WC by age, physical exercise, alcohol consumption and oral contraceptive use. In a similar procedure, total cholesLeptin pathway genes and obesity in Brazil VS Mattevi et al terol (TC) levels were adjusted for the effects of sex, age and BMI.
Mean adjusted BMI and WC were compared among genotypes by analysis of variance or Student's t-test. Homogeneity of variances was tested by the Levene's statistic and ttest for unequal variances, or nonparametric tests were used when necessary. When the analysis of variance provided significant results (P < 0.05), the post-hoc Tukey -Kramer multiple comparisons test was performed. The analyses were performed using the SPSS 8.0.0 statistical package.
Results
Subject characteristics
The characteristics of the individuals investigated are shown in Table 1 . The mean age of participants was 39.9 y. Most of the individuals in our sample (45.5%) had a normal weight (BMI < 25 kg=m 2 ), while 36.6% could be classified as overweight and 17.9% were obese (BMI ! 30 kg=m 2 ). Although the mean BMI was similar in both genders, the mean WC was significantly higher in males, as expected. 30 Genotype and allele frequencies Genotype and allele frequencies of the LEP, LEPR and NPY gene variants analyzed in normal-weight (BMI < 25 kg=m 2 ) and overweight plus obese (BMI ! 25 kg=m 2 ) individuals are shown in Table 2 . All sites were polymorphic in this population, but the NPY Leu7Pro variant was observed in low frequencies, and no Pro=Pro homozygotes were observed. Genotype frequencies at all sites were in agreement with those expected under Hardy -Weinberg equilibrium.
The genotype and allele frequencies of the LEPR Gln223Arg polymorphism were different among normalweight and overweight plus obese groups ( Table 2 , P ¼ 0.013 and 0.009, respectively). Residuals analysis showed that this difference is due to a reduction of the Gln=Gln genotype in normal-weight individuals and an excess of the Arg=Arg genotype in overweight individuals (Table 2 ). No differences in frequencies were observed for the three other polymorphic loci.
Genotype frequencies of LEPR Gln223Arg were compared among individuals with and without central-type obesity (Table 3) . No differences were observed in women. However, in the male sample, the Arg=Arg genotype was more frequent in individuals with central adiposity (WC ! 102 cm). 
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Associations of gene polymorphisms with anthropometric variables
As there were no differences in the mean adjusted BMI between men and women, the two samples were combined for this analysis (Table 4 ). In the whole sample, no associations were observed for LEP A19G, LEPR PRO1019pro and NPY Leu7Pro polymorphisms. Although there was no difference in the mean adjusted BMI among LEPR Gln223Arg genotypes, a trend for Arg=Arg individuals to have higher mean BMI compared to Gln=Gln homozygotes was observed, with heterozygote individuals presenting an intermediate mean BMI between the two homozygote groups (ANOVA, P ¼ 0.063; Table 4 ). Since the mean adjusted WC was very different between genders, it was analyzed as a quantitative variable in each sex separately, but no significant associations were observed (Table 3) .
Although smoking did not contribute significantly to the regression models used for the adjustments of the anthropometric variables, it is an environmental variable that may exert some effect on BMI and WC, and thus may constitute a confounding factor. In order to eliminate the effect of smoking on BMI, the association analysis between BMI and LEPR Gln223Arg genotypes was subsequently restricted to the 232 non-smokers in our sample (Table 5 ). In these individuals, the LEPR Gln223Arg polymorphism showed a highly significant effect on BMI (P ¼ 0.009). The Tukey -Kramer multiple comparisons test showed that the observed difference in mean BMI was due to Arg=Arg homozygotes, which had a significantly higher BMI vs both heterozygotes and Gln=Gln homozygotes.
Despite the lack of apparent effect of the NPY Leu7Pro variant on BMI in the whole sample, when we restricted the analysis to premenopausal women, a highly significant effect of NPY emerged. Women bearing the Pro variant had a lower BMI than wild-type homozygotes (P ¼ 0.001; Table 6 ).
Since a previous study 20 has described an association of the NPY Leu7Pro polymorphism with high serum total and LDL cholesterol levels, we compared mean adjusted cholesterol levels among NPY genotypes in our sample. However, Leu=Leu homozygotes presented mean adjusted total cholesterol levels ( AE s.d.) equal to 5.07 AE 0.94 mmol=l, while Pro carriers had somewhat lower TC levels (4.92 AE 0.92 mmol=l; unpaired t-test, P ¼ 0.508), providing evidence that the effect of the NPY Leu7Pro variant observed here is not merely a consequence of some association with cholesterol levels. Leptin pathway genes and obesity in Brazil VS Mattevi et al
Discussion
In this study, we evaluated the association of four common polymorphisms in genes involved in the leptin signaling pathway with obesity in a Brazilian population of European descent.
The allele frequencies detected in our population were in the same range of those observed in other Caucasian populations. 2 -5,8,9,11 -17,20 In agreement with most previous works, 2 -4 this study failed to find an association between the LEP A19G variant and BMI. Among the three genes analyzed, LEP, LEPR and NPY, only LEPR showed consistent effects in our sample. Of the two LEPR polymorphisms studied in our sample, only the Gln223Arg variant was associated with obesity-related phenotypes, while the PRO1019pro polymorphism did not appear to have any effect over these traits. Gln223Arg is a non-conservative amino acid change that results from an A to G substitution in the second position of codon 223. On the other hand, PRO1019pro is a silent G to A transition at codon 1019. Chagnon et al 14 proposed that the amino acid substitution observed at residue 223 may change the signaling capacity of LEPR, as it is located in exon 6, which is situated near the first of two duplicate cytokine motifs that represent two putative leptin-binding regions. 10, 31, 32 Results presented here are suggestive of some functional effect of the Gln223Arg substitution on the protein produced by the mutant allele.
Of the 12 investigations 7 -18 reported so far, five 13,14,16 -18 showed significant associations between the LEPR Gln223Arg polymorphism and obesity-related traits. Recently Heo et al 33 analyzed raw pooled data from some of these studies, and reported a lack of association with BMI or WC. However, as these investigators pointed out, this absence of association does not necessarily indicate that the Gln223Arg polymorphism does not play a role in obesity. A possible reason may be that these studies were performed in populations with background variation in other genes, which may hide the effects of the LEPR gene. When studying polygenic traits, it is important to keep in mind that, generally, each gene contributes with a small to moderate percentage of the trait variance, which implies that the same disorder in different groups may be caused by different combinations of polygenes. 34 Our results are in agreement with the data recently published by Chagnon et al, 14 who observed that Caucasian North-American males carrying the Arg allele exhibit a higher mean BMI and fat mass. Another recent study 18 in a Greek population sample obtained results very similar to those described here.
Genotype, environment and its interactions are important in the determination of multifactorial diseases, such as obesity. Smokers tend to weigh less, and this could constitute a confounding factor. As pointed out by Willett et al, 35 even when data on smoking are available, simple statistical adjustments for smoking are not entirely satisfactory, because nuances such as depth of inhalation and genetic susceptibility, which cannot be accounted for, could influence the effect of smoking on body weight and mortality. Therefore, as suggested by these authors, we performed an analysis restricted to non-smokers, which showed a much stronger association between LEPR Gln223Arg and BMI, even though the sample is smaller, showing the usefulness of considering external factors that could mask the phenotypic effects of obesity candidate genes, which may also be one of the reasons why some studies were not able to identify the same effect observed here. Smoking was not considered a covariate in Heo et al 33 metaanalysis. In the analysis of complex phenotypes, such as obesity, the relationship between phenotype and genotype may be context-dependent, such that genes act differently in the two sexes or change as a function of age. 36 In our study, we found an association of the LEPR Arg=Arg genotype with abdominal adiposity restricted to males only. Different studies have demonstrated a marked sexual dimorphism in circulating leptin concentrations (reviewed by Rosenbaum et al 37 ) , and it is believed that these gender differences are predominantly due to gonadal steroids. Estrogen and androgen receptors are expressed in neurons of hypothalamic nuclei that affect energy homeostasis systems. Because of these receptors, gonadal steroids are strong candidates to modulate the sensitivity of the central nervous system to leptin-mediated signals, 30 and might account for the genderspecific effects observed in some gene variants.
The NPY Leu7Pro polymorphism effect was observed not only as gender-specific, but also restricted to premenopausal women. As some studies 30 have demonstrated, gonadal steroids may affect systems regulating energy homeostasis, and the decline of estrogen production which occurs at menopause may provide an explanation for the NPY Leu7Pro polymorphism effect observed only in premenopausal women in our study. Clearly, our results for the NPY polymorphism, although highly significant, are based on a small sample of seven carriers of the Pro variant. Moreover, few studies have, as yet, been performed with this gene variant. 19 -21 Therefore, further investigations of this gene in populations from different genetic backgrounds could provide helpful results to clarify this issue.
In summary, our findings suggest that genetic variability in the leptin receptor and neuropeptide Y genes is implicated in body weight regulation, the LEPR Gln223Arg variant being associated with a BMI increase in this Caucasian population, especially in non-smokers, while the NPY Leu7Pro polymorphism is associated with BMI reduction in premenopausal women. These results reinforce the importance of considering genotype -environment interactions when studying complex multifactorial traits, such as body fat accumulation and distribution. 
